Companies · Biotechnology

Healthtech Solutions, Inc./UT

TUCKAHOE · Biotechnology

Diligence memoA one-page analyst read on Healthtech Solutions, Inc./UT — recommendation, valuation, rhythm, risks.
$3.4M
Total raised · real
2
Rounds
3.3×
Latest step-up
Top 65%
Sector rank · raised
Seed
Latest stage · inferred · Thu May 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Healthtech Solutions, Inc./UT looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the biotech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 1.12× the median modeled value of Seed Biotechnology companies in 2019–2021 (186 peers) — value vs value, same stage and era.
  • Within the normal band (112% of peer median) for its niche.
Dormant
  • Last raise 5.2 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Biotechnology

Healthtech Solutions, Inc./UT is one of 4293 Biotechnology companies tracked from TUCKAHOE. By capital raised it ranks in the long tail (ahead of 36% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

healthtech

As reported in public records reported — not modeled.

US
Jurisdiction
No revenue
Issuer revenue
Rule 506(b)
Reg D exemption
30
Investors (latest)
2021-05-06
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$25M$50M$75M$100MPre-Seed · 2020-11-16 Raised $782K (real) Modeled valuation $34M (est)$782K$34MPre-Seed2020Seed · 2021-05-06 Raised $2.6M (real) Modeled valuation $72M (est)$2.6M$72MSeed2021+$2.6MCumulative $3.4M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$782K · 2020
Seed$2.6M · 2021

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$72.2M
Base estimate est.
$1.9M
Conservative case
$450.9M
Upside case
$13.0M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seeda $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the biotech sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $34.2M · 2020-11-162020Seed · modeled $72.2M · 2021-05-062021
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
32%
Survival probability
14% low · 50% high
1.74×/yr
Annual markup
2.28×/yr upside case
5.2 yr
Elapsed time used
5.2 yr actual, capped for stale marks
biotech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
6 mo
Avg between rounds
$7.2M/yr
Capital velocity
5.6 yr
On record since
2020
First round
2
Rounds on file
How it compares to the market

Benchmarked against 4293 companies in Biotechnology. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.5× of median
This company$3.4M
Sector median$7.2M
Latest round — vs other Seed rounds in sector (real $, this stage) 1.5× above median
This company$2.6M
Sector median$1.7M
Modeled value — vs sector median (estimate, all stages) 1.1× above median
This company$72.2M
Sector median$64.2M

Raised more than 36% of sector peers (real $). Modeled value above 52% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #66 of 186.

This companyCohort peer
$10.0M$100.0M$1.0B$1.0M$10.0MCapital raised (log)Novo Biosciences, Inc. · Seed Raised $4.0M · modeled $177.6M (est)Entac Medical, Inc. · Seed Raised $4.0M · modeled $177.6M (est)ReGelTec, Inc. · Seed Raised $6.0M · modeled $177.6M (est)Korro Bio, Inc. · Seed Raised $4.0M · modeled $177.6M (est)TamuroBio Inc. · Seed Raised $4.0M · modeled $177.6M (est)Initial Therapeutics, Inc. · Seed Raised $3.8M · modeled $168.6M (est)Helaina Inc · Seed Raised $4.4M · modeled $165.0M (est)Onchilles Pharma, Inc. · Seed Raised $3.6M · modeled $158.5M (est)UVision 360, Inc. · Seed Raised $4.6M · modeled $155.7M (est)Safeguard Biosystems Holdings Ltd · Seed Raised $3.5M · modeled $155.4M (est)Enable Medicine Inc. · Seed Raised $3.6M · modeled $152.3M (est)Newomics Inc. · Seed Raised $3.9M · modeled $149.0M (est)Healthtech Solutions, Inc./UT (this company) Raised $3.4M · modeled $72.2M (est)Healthtech Solutions, Inc./UT
CompanyStageRaised · realValue · estvs peer med.
Novo Biosciences, Inc.Seed$4.0M$177.6M2.76×
Entac Medical, Inc.Seed$4.0M$177.6M2.76×
ReGelTec, Inc.Seed$6.0M$177.6M2.76×
Korro Bio, Inc.Seed$4.0M$177.6M2.76×
TamuroBio Inc.Seed$4.0M$177.6M2.76×
Initial Therapeutics, Inc.Seed$3.8M$168.6M2.62×
Helaina IncSeed$4.4M$165.0M2.57×
Onchilles Pharma, Inc.Seed$3.6M$158.5M2.47×
UVision 360, Inc.Seed$4.6M$155.7M2.42×
Safeguard Biosystems Holdings LtdSeed$3.5M$155.4M2.42×
Enable Medicine Inc.Seed$3.6M$152.3M2.37×
Newomics Inc.Seed$3.9M$149.0M2.32×
Healthtech Solutions, Inc./UT this companySeed$3.4M$72.2M1.12×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$782K2020-11-16$4.3M$34.2M90%
Seed$2.6M2021-05-06$13.0M$72.2M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$782K2020-11-16
    • First recorded raise — entered as Pre-Seed.
    • 5 investors on this round.
  2. Seed$2.6M2021-05-06
    • Came back fast: 6 mo vs the ~14 mo sector norm.
    • Round 3.3× larger than the prior — scaling up.
    • 30 investors on this round.
Intelligence
2021 ~Q4
Modeled next raise · ~6mo cadence
$7.8M
Modeled next size est.range $5.1M$12.5M
3.3×
Last step-up
$7.2M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
David Rubin10 other2020-11
Denis E. Kleinfeld2020-11
Edward E. Swanson2021-05
Manuel E. Iglesias2020-11
Robert E. Brantl2021-05
Registry & provenance

Healthtech Solutions, Inc./UT is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1307624
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Polaris Quantum Biotech, Inc.BiotechnologySeed$3.4M$71.7Msame sector · same stage
Arbovax, Inc.BiotechnologySeed$3.4M$75.3Msame sector · same stage
Smisson-Cartledge Biomedical, LLCBiotechnologySeed$3.4M$88.8Msame sector · same stage
Phenomune, LLCBiotechnologySeed$3.3M$81.5Msame sector · same stage
CDI Laboratories, Inc.BiotechnologySeed$3.3M$70.7Msame sector · same stage
Evercrisp Biosciences, Inc.BiotechnologySeed$3.5M$84.0Msame sector · same stage
Expansion Technologies, Inc.BiotechnologySeed$3.5M$66.6Msame sector · same stage
Inventprise LLCBiotechnologySeed$3.5M$74.2Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
HealthTech Solutions, Inc.HealthtechPre-Seed$34.5M88%
Innovative Health Solutions, Inc.BiotechnologySeries A$345.9M86%
Livestock Health Solutions, LLCHealthtechSeries A$270.9M84%
Gene Solutions LlcBiotechnologySeries A$192.7M84%
Healthcare Integrated Technologies Inc.BiotechnologySeries A$13.2M83%
Pi Health Inc.BiotechnologySeries C$422.2M83%
Azure Health Technology LtdBiotechnologyPre-Seed$19.5M83%
Health Care Solutions Inc.HealthtechSeed$26.8M82%
Frequently asked
How much funding has Healthtech Solutions, Inc./UT raised?
Healthtech Solutions, Inc./UT has raised approximately $3.4M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Healthtech Solutions, Inc./UT's estimated valuation?
Provath's modeled valuation for Healthtech Solutions, Inc./UT is approximately $72.2M (modeled range $1.9M–$450.9M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Healthtech Solutions, Inc./UT at?
Healthtech Solutions, Inc./UT's latest modeled financing stage is Seed. Its most recent recorded round closed around Thu May 06.
What does Healthtech Solutions, Inc./UT do and where is it based?
Healthtech Solutions, Inc./UT operates in the Biotechnology sector, based in TUCKAHOE.
Explore related

See where Healthtech Solutions, Inc./UT sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Healthtech Solutions, Inc./UT, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.